2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

[PDF][PDF] 2015 年中国恶性肿瘤流行情况分析

郑荣寿, 孙可欣, 张思维, 曾红梅, 邹小农, 陈茹… - 中华肿瘤 …, 2019 - researchgate.net
目的汇总分析各省肿瘤登记处上报的2015 年恶性肿瘤登记数据, 估算全国2015
年恶性肿瘤流行情况. 方法收集整理各省501 个登记处上报的2015 年肿瘤登记数据 …

Lung cancer immunotherapy: progress, pitfalls, and promises

A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …

Breast cancer statistics, 2022

AN Giaquinto, H Sung, KD Miller… - CA: a cancer journal …, 2022 - Wiley Online Library
This article is the American Cancer Society's update on female breast cancer statistics in the
United States, including population‐based data on incidence, mortality, survival, and …

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

C Xia, X Dong, H Li, M Cao, D Sun, S He… - Chinese medical …, 2022 - mednexus.org
Background: The cancer burden in the United States of America (USA) has decreased
gradually. However, China is experiencing a transition in its cancer profiles, with greater …

Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized …

E Versteijne, JL van Dam, M Suker… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE The benefit of neoadjuvant chemoradiotherapy in resectable and borderline
resectable pancreatic cancer remains controversial. Initial results of the PREOPANC trial …

Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology

RI Haddad, L Bischoff, D Ball, V Bernet… - Journal of the National …, 2022 - jnccn.org
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of
choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation …

Targeted therapies for lung cancer patients with oncogenic driver molecular alterations

AC Tan, DSW Tan - Journal of Clinical Oncology, 2022 - ingentaconnect.com
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …

Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers

FJ Lowery, S Krishna, R Yossef, NB Parikh, PD Chatani… - Science, 2022 - science.org
The accurate identification of antitumor T cell receptors (TCRs) represents a major challenge
for the engineering of cell-based cancer immunotherapies. By mapping 55 neoantigen …